
Meridian Bioscience VIVO
Quarterly report 2022-Q4
added 02-09-2023
Meridian Bioscience Historical Prices 2011-2026 | VIVO
Annual Historical Prices Meridian Bioscience
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 31.8 | 20.4 | 18.7 | 9.77 | 17.1 | 13.3 | 16.2 | 18 | 13.8 | 21.5 | 15.8 | 14.1 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 31.8 | 9.77 | 17.6 |
Historical Prices of other stocks in the Diagnostics research industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.38 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
139 | $ 118.25 | -1.27 % | $ 35.9 B | ||
|
Burning Rock Biotech Limited
BNR
|
8.43 | $ 22.5 | 9.44 % | $ 242 M | ||
|
Accelerate Diagnostics
AXDX
|
0.49 | - | -61.36 % | $ 2.46 M | ||
|
Aspira Women's Health
AWH
|
0.39 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
0.35 | - | -13.05 % | $ 7.29 M | ||
|
Check-Cap Ltd.
CHEK
|
0.74 | - | - | $ 9.42 M | ||
|
Chembio Diagnostics
CEMI
|
0.39 | - | 0.22 % | $ 16.8 M | ||
|
CareDx, Inc
CDNA
|
18.6 | $ 22.42 | 27.6 % | $ 1.19 B | ||
|
DermTech
DMTK
|
1.3 | - | -11.32 % | $ 2.94 M | ||
|
Akumin
AKU
|
0.84 | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
1.13 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
4.4 | $ 1.46 | 2.82 % | $ 1.94 M | ||
|
Exact Sciences Corporation
EXAS
|
103 | - | - | $ 19.8 B | ||
|
Castle Biosciences
CSTL
|
25.5 | $ 24.56 | -0.24 % | $ 682 M | ||
|
Global Cord Blood Corporation
CO
|
2.5 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
1.44 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
0.87 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
155 | $ 176.94 | -2.0 % | $ 8.77 B | ||
|
Danaher Corporation
DHR
|
210 | $ 193.78 | -2.18 % | $ 138 B | ||
|
Interpace Biosciences
IDXG
|
1.66 | $ 2.2 | - | $ 9.73 M | ||
|
Heska Corporation
HSKA
|
81.6 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.36 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
103 | $ 132.72 | 0.35 % | $ 21.1 B | ||
|
Fulgent Genetics
FLGT
|
15.4 | $ 16.13 | -0.25 % | $ 488 M | ||
|
Koninklijke Philips N.V.
PHG
|
32 | $ 28.63 | -1.58 % | $ 20 B | ||
|
Medpace Holdings
MEDP
|
449 | $ 515.65 | -0.56 % | $ 14.9 B | ||
|
Guardant Health
GH
|
107 | $ 85.7 | 0.99 % | $ 10.7 B | ||
|
QIAGEN N.V.
QGEN
|
38.3 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
3.19 | $ 2.83 | -3.41 % | $ 91.8 K | ||
|
Biomerica
BMRA
|
3.13 | $ 2.2 | 4.27 % | $ 5.05 M | ||
|
Motus GI Holdings
MOTS
|
0.64 | - | -34.28 % | $ 263 K | ||
|
ICON Public Limited Company
ICLR
|
201 | $ 115.58 | -0.79 % | $ 9.53 B | ||
|
Laboratory Corporation of America Holdings
LH
|
287 | $ 266.36 | -0.14 % | $ 22.2 B | ||
|
Celcuity
CELC
|
115 | $ 125.25 | 1.44 % | $ 5.86 B | ||
|
Lantheus Holdings
LNTH
|
75.9 | $ 83.92 | -0.02 % | $ 5.66 B | ||
|
Myriad Genetics
MYGN
|
4.42 | $ 5.0 | -3.66 % | $ 463 M | ||
|
NeoGenomics
NEO
|
11.6 | $ 8.16 | -5.99 % | $ 1.05 B | ||
|
Neogen Corporation
NEOG
|
4.7 | $ 9.24 | -1.91 % | $ 2 B | ||
|
Quest Diagnostics Incorporated
DGX
|
210 | $ 191.46 | 0.02 % | $ 21.3 B | ||
|
ENDRA Life Sciences
NDRA
|
4.65 | $ 5.17 | 0.58 % | $ 4.07 M | ||
|
National Research Corporation
NRC
|
14.1 | $ 17.62 | -1.23 % | $ 394 M | ||
|
Invitae Corporation
NVTA
|
2.17 | - | - | $ 21.2 M | ||
|
Natera
NTRA
|
53.9 | $ 196.11 | -5.35 % | $ 19.3 B | ||
|
Organovo Holdings
ONVO
|
2.12 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
1.96 | - | -16.95 % | $ 1.54 M | ||
|
PerkinElmer
PKI
|
115 | - | -0.91 % | $ 14.7 B |